|
ACHD |
Atherosclerotic Coronary Heart Disease |
|
|
ACHIEVE |
Accupril Congestive Heart Failure Investigation And Economic Variable Evaluation |
|
|
AD-CHF |
Acutely Decompensated Congestive Heart Failure |
|
|
AE |
Aryepiglottic |
|
|
AE |
Apoenzyme |
|
|
AH |
artificial heart |
|
|
AHA |
American Heart Association |
|
|
AHA/ACC |
American Heart Association/American College Of Cardiology |
|
|
AHD |
Arteriosclerotic Heart Disease |
|
|
AHES |
artificial heart energy system |
|
|
AHF |
Acute Heart Failure |
|
|
AHF SCENE |
Advanced Heart Failure Shared Clinical Experience Network |
|
|
AHMA |
Antiheart Muscle Autoantibody |
|
|
AHMD |
Alcoholic Heart Muscle Disease |
|
|
AHR |
atrial heart rate |
|
|
AHR |
Aryl Hydrocarbon Receptor |
|
|
ALLHAT |
Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial |
|
|
ANZ |
Australia and New Zealand |
|
|
APD |
VERP)/action potential duration |
|
|
APDB |
Action Potential Duration-baseline Beat |
|
|
APDP |
Action Potential Duration-premature Stimulus |
|
|
APPROACH |
Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease |
|
|
ASHD |
Arteriosclerotic Heart Disease |
|
|
ASHD |
Atrioseptal Heart Disease |
|
|
ASHD |
AtheroSclerotic Heart Disease |
|
|
AVHD |
Acquired Valvular Heart Disease |
|
|
AVHS |
acquired valvular heart syndrome |
|
|
BASH |
Body Acceleration Synchronous With Heart Rate |
|
|
BCHT |
Bicaval Heart Transplantation |
|
|
BFHR |
Basal Fetal Heart Rate |
|
|
BHAT |
Beta-Blocker Heart Attack Trial |
|
|
BHF |
British Heart Foundation |
|
|
BHFS |
Benzapril Heart Failure Study |
|
|
BHI |
Brain-heart Infusion |
|
|
BHIA |
Brain-Heart Infusion Agar |
|
|
BHIBA |
Brain-Heart Infusion Blood Agar |
|
|
BHIRS |
Brain-heart Infusion And Rabbit Serum |
|
|
BHIS |
beef heart infusion supplemented |
|
|
BHR |
basal heart rate |
|
|
BHS |
Bogalusa Heart Study |
|
|
BHS |
Brisighella Heart Study |
|
|
BMH |
Biomechanical Heart |
|
|
BRH |
British Regional Heart |
|
|
BRHS |
British Regional Heart Study |
|
|
CAHD |
Coronary Arteriosclerotic Heart Disease |
|
|
CARMEN |
Carvedilol Angiotensin Converting Enzyme Inhibitors Remodelling Mild Heart Failure Evaluation |
|
|
CASCO |
Calcium Sensitization in Congestive Heart Failure |
|
|
CASHD |
Coronary Arteriosclerotic Heart Disease |
|
|
CCF |
congestive heart failure |
|
|
CCHD |
Cyanotic Congenital Heart Disease |
|
|
CCHD |
Caephilly Collaborative Heart Disease |
|
|
CCHP |
Corpus Christi Heart Project |
|
|
CCHS |
Copenhagen City Heart Study |
|
|
CEHC |
calf embryonic heart cell |
|
|
CESNA II |
Comparative Efficacy And Safety Of Nisoldipine And Amlodipine |
|
|
CHANGE |
Chronic Heart Failure And Graded Exercise |
|
|
CHAOS |
Cambridge Heart Antioxidant Study |
|
|
CHAPS |
Carvedilol Heart Attack Pilot Study |
|
|
CHARM |
Candesartan In Heart Failure Assessment In Reduction Of Mortality |
|
|
CHB |
congenital heart block |
|
|
CHB |
Complete Heart Block |
|
|
CHD |
Coronary Heart Disease |
|
|
CHD |
Congenital Heart Disease |
|
|
CHD |
Cyanotic heart disease |
|
|
CHF |
Congestive Heart Failure |
|
|
CHF |
Chronic Heart Failure |
|
|
CHF-IES |
Congestive Heart Failure-Italian Epidemiological Study |
|
|
CHF-STAT |
Congestive Heart Failure-Survival Trial Of Antiarrhythmic Therapy |
|
|
CHFDT |
Congestive Heart Failure Data Tool |
|
|
CHIME |
Coloboma, Heart Anomaly, Ichthyosis, Mental Retardation, Ear Abnormality |
|
|
CHLS |
combined heart and lung surgery |
|
|
CHOICE |
Congestive Heart Failure Mortality: Investigation On Carvedilol's Efficacy |
|
|
CHOICE |
Caring For Hypertension On Initiation: Cost And Effectiveness |
|
|
CHOICES |
Cancer, Heart Disease, Osteoporosis Interventions, And Community Evaluation Studies |
|
|
CHS |
Charleston Heart Study |
|
|
CHS |
Coronary Heart Study |
|
|
CHS |
Congenital Heart Surgeons Society study |
|
|
CHS |
Copenhagen City Heart Study |
|
|
CHT |
classical heart transplantation |
|
|
CLA |
closed loop algorithm |
|
|
CLH |
cleft limb-heart |
|
|
CM |
CarboMedics |
|
|
CMH |
Congenital Malformation of the Heart |
|
|
CNTHM |
Conotruncal Heart Malformation |
|
|
CONGHD |
Congenital Heart Disease |
|
|
CSCHDS |
Caerphilly and Speedwell Collaborative Heart Disease Studies |
|
|
CVHD |
chronic valvular heart disease |
|
|
DAH |
Disordered Action of the Heart |
|
|
DHFS |
Diet-Heart Feasibility Study |
|
|
DIAMOND-CHF |
Danish Investigation Of Arrhythmia And Mortality On Dofetilide In Congestive Heart Failure |
|
|
DRFS |
Dundee Rank Factor Score |
|
|
EH |
Enlarged Heart |
|
|
EHV |
electric heart vector |
|
|
EHVT |
Edinburgh Heart Valve Trial |
|
|
EIHDW |
Evaluation of Ischemic Heart Disease in Women |
|
|
ELVD-CHF |
Exercise In Left Ventricular Dysfunction And Chronic Heart Failure |
|
|
ENRICAD |
Enhancing Recovery In Coronary Heart Disease |
|
|
ENRICHD |
Enchancing Recovery In Coronary Heart Disease Patients |
|
|
ESCAPE |
evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness |
|
|
EUROWINTER |
European Study On Cold Exposure And Winter Mortality From Ischemic Heart Disease |
|
|
FBPM |
forward-backward Prony method |
|
|
FH |
Fetal Heart |
|
|
FHF |
fetal heart frequency |
|
|
FHH |
Fetal Heart Heard |
|
|
FHNH |
Fetal Heart not Heard |
|
|
FHR |
Fetal Heart Rate |
|
|
FHRNST |
Fetal Heart Rate Nonstress Test |
|
|
FHS |
Framingham Heart Study |
|
|
FHS |
Fetal heart sound |
|
|
FHS |
Family Heart Study |
|
|
FHT |
fetal heart tone |
|
|
FHT |
Fetal Heart Tracing |
|
|
FP |
fast pathway |
|
|
GWTG |
Get with the Guidelines |
|
|
H |
Hearth |
|
|
H&L |
Heart And Lung |
|
|
H-L-K |
Heart, Liver, And Kidneys |
|
|
HAL |
Heart Attacks in London |
|
|
HAPORT |
Heart Attack Patient Outcome Research Team |
|
|
HAPPHY |
Heart Attack Primary Prevention in Hypertension |
|
|
HASHD |
Hypertensive Arteriosclerotic Heart Disease |
|
|
HB |
Heart Block |
|
|
HBP |
Heartbeat Period |
|
|
HCA |
heart cell aggregate |
|
|
HD |
Heart Disease |
|
|
HDDRISC |
Heart Disease and Diabetes Risk Indicators in a Screened Cohort |
|
|
HDH |
heart disease history |
|
|
HDP |
Heart Disease Program |
|
|
HDRF |
Heart Disease Research Foundation |
|
|
he |
heart |
|
|
HeFT |
heart failure trial |
|
|
HEHR |
Highest Equivalent Heart Rate |
|
|
HELP |
Heart European Leaders Panel |
|
|
HERS |
Heart And Estrogen-Progestin Replacement Study |
|
|
HF |
Heart Failure |
|
|
Hfr |
heart frequency |
|
|
HHD |
Hypertensive Heart Disease |
|
|
HHP |
Honolulu Heart Program |
|
|
HHS |
Helsinki Heart Study |
|
|
HHS |
Hyperkinetic Heart Syndrome |
|
|
HHS |
Honolulu Heart Study |
|
|
HHT |
Heterotopic Heart Transplantation |
|
|
HI |
heart infusion |
|
|
Hib |
heart infusion broth |
|
|
HIC |
Heart Information Center |
|
|
HL |
Heart And Lungs |
|
|
HLA |
Heart Lungs Abdomen |
|
|
HLHS |
Hypoplastic Left Heart Syndrome |
|
|
HLK |
Heart, Liver, Kidney |
|
|
HLM |
Heart-Lung Machine |
|
|
HLR |
Heart-to-lung Ratio |
|
|
HLT |
Heart-lung Transplantation |
|
|
HLTX |
Heart-lung Transplant |
|
|
HM |
Heart Murmur |
|
|
HMO |
heart minute output |
|
|
HPLH |
Hypoplastic Left Heart Syndrome |
|
|
HPS |
Heart Protection Study |
|
|
HR |
Heart Rate |
|
|
HRA |
heart rate audiometry |
|
|
HRA |
heart-reactive antibody |
|
|
HRF |
Heart rate fluctuations |
|
|
HRMAX |
Maximal Heart Rate |
|
|
HRR |
Heart Rate Range |
|
|
HRRI |
heart rate retardation index |
|
|
HRRR |
Heart regular rate and rhythm |
|
|
HRSUB |
Submaximal Heart Rate |
|
|
hrt |
heart rate |
|
|
HRT |
Heart Rate Training (exercise) |
|
|
HRV |
BACKGROUND:Heart rate variability |
|
|
HS |
Heart Sounds |
|
|
HSEP |
heart synchronized evoked potential |
|
|
ht |
Heart Trouble |
|
|
ht |
Heart Throb |
|
|
HTHD |
Hypertensive Heart Disease |
|
|
HTx |
Heart Transplantation |
|
|
HV |
heart volume |
|
|
HW |
heart weight |
|
|
HWBW |
Heart Weight to Body Weight |
|
|
HWD |
Heartworm Disease |
|
|
HWI |
Heart weight index |
|
|
HWI |
Heart work index |
|
|
I(TO) |
Transient Outward Current |
|
|
IAH |
implantable artificial heart |
|
|
IB |
Background Sodium Current |
|
|
ICHD |
Intersociety Commission for Heart Disease Resources |
|
|
ICL |
Chloride Ionic Current |
|
|
IDHS |
Indian Diet Heart Study |
|
|
If |
hyperpolarization-activated current |
|
|
IHD |
Ischemic Heart Disease |
|
|
IHD SDP |
Ischemic Heart Disease Shared Decision-Making Program |
|
|
IHDI |
Ischemic Heart Disease Index |
|
|
IHDPORT |
Ischemic Heart Disease Patient Outcomes Research Team |
|
|
IHHS |
idiopathic hyperkinetic heart syndrome |
|
|
IHR |
Intrinsic Heart Rate |
|
|
IIHD |
Israeli Ischemic Heart Disease |
|
|
IK-ACH |
Acetylcholine-induced Potassium Current |
|
|
IKADO |
Outward Inwardly Rectifying Potassium Current |
|
|
IKI |
Inward Rectifier Current |
|
|
IKP |
Plateau Potassium Current |
|
|
IKR |
Rectified Potassium Current |
|
|
IN-CHF |
Italian Network Congestive Heart Failure |
|
|
INa |
inward sodium current |
|
|
ISHLT |
The International Society For Heart And Lung Transplantation |
|
|
Isht |
International Society for Heart Transplantation |
|
|
Kihd |
Kuopio Ischemic Heart Disease Risk Factor Study |
|
|
L&H |
Lungs and heart |
|
|
L/H |
Lung-to-heart |
|
|
LD1 |
Isoenzyme Of Lactate Dehydrogenase Found In The Heart, Erythrocytes, And Kidneys |
|
|
LH |
left heart |
|
|
LHBV |
Left Heart Blood Volume |
|
|
LHC |
Left Heart Catheterization |
|
|
LHF |
Left Heart Failure |
|
|
LHS |
left heart strain |
|
|
LHS |
Lung Heart Study |
|
|
LHT |
Lifestyle Heart Trial |
|
|
LIHFE |
living with heart failure |
|
|
LRL |
lower rate limit |
|
|
M-HART |
Montreal Heart Attack Readjustment Trial |
|
|
MACH |
Mortality Assessment in Congestive Heart Failure |
|
|
MBPM |
modified backward Prony method |
|
|
MDHR |
maximum determined heart rate |
|
|
MERIT-HF |
Metoprolol Controlled-release Randomised Intervention Trial in Heart Failure |
|
|
MH |
Medtronic Hall |
|
|
MHD |
Mulberry Heart Disease |
|
|
MHFT |
Munich Mild Heart Failure Trial |
|
|
MHHP |
Minnesota Heart Health Program |
|
|
MHHS |
Minnesota Heart Health Survey |
|
|
MHR |
Maternal Heart Rate |
|
|
MHS |
Minnesota Heart Survey |
|
|
MHV |
Magnetic Heart Vector |
|
|
MICRO-HOPE |
Microalbuminuria, Cardiovascular And Renal Outcomes-Heart Outcomes Prevention Evaluation |
|
|
MISCHF |
Management to Improve Survival in Congestive Heart Failure |
|
|
MLCCHF |
Multicenter Lisinopril Captopril Congestive Heart Failure |
|
|
MOCHA |
Multicenter Oral Carvedilol In Heart Failure Assessment |
|
|
MPHR |
Maximum Predicted Heart Rate |
|
|
MRC/BHF |
Medical Research Council, British Heart Foundation Heart Protection Study |
|
|
NAHC |
National Advisory Heart Council |
|
|
NDHS |
National Diet-Heart Study |
|
|
NHAAP |
National Heart Attack Alert Program |
|
|
NHBCD |
Non-Heart-Beating Cadaver Donor |
|
|
NHF |
National Heart Foundation |
|
|
NHI |
National Heart Institute |
|
|
NHLBI |
National Heart, Lung, and Blood Institute |
|
|
NHLBI II |
National Heart, Lung And Blood Institute Type II |
|
|
NHLBI-ICD |
National Heart, Lung And Blood Institute Implantable Cardioverter Defibrillator |
|
|
NHLBI-PTCA |
National Heart, Lung And Blood Institute Percutaneous Transluminal Coronary Angioplasty |
|
|
NHLBITS |
National Heart, Lung, and Blood Institute Twin Study |
|
|
NHLI |
National Heart and Lung Institute |
|
|
NHS-1 |
First Natural History Study |
|
|
NHS-2 |
Second Natural History Study |
|
|
NIPS |
Noninvasive Programmed heart Stimulation |
|
|
NPHS |
Northwick Park Heart Study |
|
|
NYHA |
New York Heart Association |
|
|
NYHAFC |
New York Heart Association Functional Class |
|
|
OH |
open heart |
|
|
OHD |
Organic Heart Disease |
|
|
OHS |
Open Heart Surgery |
|
|
OHT |
Orthotopic Heart Transplantation |
|
|
OHT |
Oslo Heart Trial |
|
|
OPTIME |
Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations |
|
|
OPTIME CHF |
Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic HeartFailure |
|
|
PHARM |
Pharmacist In Heart Failure: Assessment, Recommendation And Monitoring |
|
|
PHAVER |
Pterygia-heart Defects-autosomal Recessive Inheritance-vertebral Defects-ear Anomalies-radial Defects |
|
|
PHHP |
Pawtucket Heart Health Program |
|
|
PHR |
Peak Heart Rate |
|
|
PICO |
Pimobendan in Congestive Heart Failure |
|
|
PLET |
Polymyxin, Lysosome, EDTA, Thallous Acetate |
|
|
PMHR |
Predicted Maximum Heart Rate |
|
|
PRHHP |
Puerto Rico Heart Health Program |
|
|
PRIME |
Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure |
|
|
PsHD |
pseudoheart disease |
|
|
PW |
posterior wall |
|
|
QHFT |
Quinapril Heart Failure Trial |
|
|
QTc |
QT interval corrected for heart rate |
|
|
RCHF |
Right Congestive Heart Failure |
|
|
REACH |
Resource Utilization In Congestive Heart Failure |
|
|
REACH |
Research On Endothelin Antagonism In Chronic Heart Failure |
|
|
REMATCH |
Randomized Evaluation Of Mechanical Assistance In The Treatment Of Congestive Heart Failure |
|
|
RH |
Right Heart |
|
|
RHB |
Right heart bypass |
|
|
RHC |
right heart catheterizations |
|
|
RHF |
Right Heart Failure |
|
|
RHMV |
Right Heart Mixing Volume |
|
|
RHR |
Resting Heart Rate |
|
|
RHRV |
Relative Heart Rate Variability |
|
|
RIHD |
Radiation-Induced Heart Disease |
|
|
RK |
Restitution Constant |
|
|
RT |
Repolarization Time |
|
|
RUTH |
Raloxifene Use for The Heart |
|
|
RVHD |
Rheumatic Valvular Heart Disease |
|
|
S1-S4 |
First To Fourth Heart Sounds |
|
|
SAC |
Stretch-activated channel |
|
|
SACCAT |
Stretch-activated Channel-cations |
|
|
SAHS |
San Antonio Heart Study |
|
|
SCD-HEFT |
Sudden Cardiac Death In Heart Failure |
|
|
SDHD |
Sudden death heart disease |
|
|
SDIHD |
sudden-death ischemic heart disease |
|
|
SHARP |
Scottish Heart And Arterial Disease Risk Prevention |
|
|
SHD |
sudden heart death |
|
|
SHHS |
Scottish Heart Health Study |
|
|
SHHS |
Sleep Heart Health Study |
|
|
shs |
Strong Heart Study |
|
|
SHVRC |
Shiley Heart Valve Research Center |
|
|
SID |
Stress-induced Depolarization |
|
|
SIHDSPS |
Stockholm Ischemic Heart Disease Secondary Prevention Study |
|
|
SOM |
Sustained outward movement |
|
|
SP |
slow pathway |
|
|
SPWVD |
Smooth pseudo-Winger-Ville distribution |
|
|
STAT-CHF |
Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure |
|
|
STRETCH |
Symptom Tolerability Response To Exercise Trial Of Candesartan Cilexetil In Patients With Heart Failure |
|
|
SYMPHONY |
Sibrafiban Vs Aspirin To Yield Maximum Protection From Ischemic Heart Events Postacute Coronary Syndromes [trial] |
|
|
TAH |
Total Artificial Heart |
|
|
TCI |
To Come In (hospital appointments) |
|
|
TEAHAT |
Thrombolysis Early in Acute Heart Attack Trial |
|
|
THB |
total heart beats |
|
|
THD |
Transverse heart diameter |
|
|
THR |
Thyroid Hormone Receptor |
|
|
THR |
Targeted Heart Rate |
|
|
THS |
Turkish Heart Study |
|
|
TIAH |
Total implantation of artificial heart |
|
|
TNT |
Treatment to New Target |
|
|
UD-AHF |
UD-CG 115 BS In Acute Heart Failure |
|
|
UHR |
Underlying heart rhythm |
|
|
UKHAS |
United Kingdom Heart Attack Study Collaborative Group |
|
|
UKHEART |
United Kingdom Heart Failure Evaluation And Assessment Of Risk Trial |
|
|
V-HEFT |
Veterans Administration Heart Failure Trial |
|
|
V-HEFT |
Vasodilator Heart Failure Trial |
|
|
VAL-HEFT |
Valsartan-Heart Failure Trial |
|
|
VDH |
Valvular Disease Of The Heart |
|
|
vhd |
Visible Human Dataset |
|
|
VHD |
Ventricular Heart Disease |
|
|
VHD |
Valvular Heart Disease |
|
|
VHR |
Ventricular Heart Rate |
|
|
VSHD |
Ventricular Septal Heart Defect |
|
|
WASH |
Warfarin-Aspirin Study Of Heart Failure |
|
|
WATCH |
Warfarin Antiplatelet Trial In Chronic Heart Failure |
|
|
WHAS |
Women's Heart Attack Study |
|
|
WHAS |
Women's Health and Aging Study |
|
|
what |
Worcester Heart Attack Trial |
|
|
WHT |
Warm Heart Trial |
|
|
Xishf |
Xamoterol in Severe Heart Failure |
|